In this episode of Lung Cancer Considered, host Dr. Narjust Florez discusses ROS+1 Fusions in NSCLC, including diagnosis, treatment, and new exciting research coming down the pipeline.

Podcast Hosts:

• Narjust Florez, MD, Associate Director of the Cancer Care Equity Program and Thoracic Medical Oncologist, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical School, Boston, MA, USA  

Podcast Guests: 

• Shirish Gadgeel, MD, Chief, Division of Hematology and Oncology, Department of Internal Medicine, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA
• Lorenza Landi, MD, Director of Clinical Trials Unit: Phase 1 and Precision Medicine, National Cancer Institute Regina Elena, Rome, Italy